-+ 0.00%
-+ 0.00%
-+ 0.00%

Imattix Biomedicine announced that research results related to its PRAME tumor antigen pipeline will be presented at the 2026 European Society of Medical Oncology Conference.

Zhitongcaijing·07/17/2026 14:33:18
Listen to the news
Imattix Biomedicine announced that research results related to its PRAME tumor antigen pipeline will be presented at the 2026 European Society of Medical Oncology Conference.